iShares Biotechnology ETF
419 hedge funds and large institutions have $6.6B invested in iShares Biotechnology ETF in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 134 increasing their positions, 150 reducing their positions, and 38 closing their positions.
Holders
419
Holders Change
+20
Holders Change %
+5.01%
% of All Funds
11.3%
Holding in Top 10
42
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+27.27%
% of All Funds
1.13%
New
65
Increased
134
Reduced
150
Closed
38
Calls
$665M
Puts
$1.9B
Net Calls
-$1.23B
Net Calls Change
-$621M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$85.4M |
| 2 |
2
Citigroup
New York
|
$600M |
| 3 |
3
Millennium Management
New York
|
$54.6M |
| 4 |
4
SG Americas Securities
New York
|
$116M |
| 5 |
MAA
5
Managed Account Advisors
Jersey City,
New Jersey
|
$189M |
